TYR and early-onset autosomal dominant Alzheimer disease: The extracts exhibited strong inhibitory activity against acetylcholinesterase, butyrylcholinesterase, α-amylase, α-glucosidase, and tyrosinase, indicating potential therapeutic applications for global health issues such as skin hyperpigmentation, Alzheimer’s disease, and diabetes mellitus [31].